Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
32.37
-1.07
(-3.20%)
As of 12:10:05 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 117.32M | 130.86M | 557.45M | 768.24M |
| Low Estimate | 114.6M | 127.4M | 539.57M | 649.67M |
| High Estimate | 119.9M | 134.1M | 595.4M | 849M |
| Year Ago Sales | 63.47M | 73.47M | 329M | 557.45M |
| Sales Growth (year/est) | 84.84% | 78.13% | 69.43% | 37.81% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NKB2.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/15/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 11/25/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/5/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 11/5/2024 |
| Initiated | TD Cowen: Buy | 10/29/2024 |
Related Tickers
ICY.HA Incyte Corp
64.94
-3.79%
25K.MU Karyopharm Therapeutics Inc
0.5920
0.00%
ICY.DU Incyte Corp
65.22
-3.72%
ICY.F Incyte Corporation
66.78
-5.06%
GNPX Genprex, Inc.
0.3350
-3.74%
ONCY Oncolytics Biotech Inc.
0.6368
-3.95%
INCY Incyte Corporation
69.67
-0.85%
SYRS Syros Pharmaceuticals, Inc.
0.0814
-0.73%
DRUG Bright Minds Biosciences Inc.
32.51
-6.92%
HUMA Humacyte, Inc.
3.2200
+5.40%